24 related articles for article (PubMed ID: 2166720)
1. Exploring six-coordinate germanium(IV)-diketonate complexes as anticancer agents.
Mertens RT; Parkin S; Awuah SG
Inorganica Chim Acta; 2020 Apr; 503(1):. PubMed ID: 34565828
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
Ettinger DS; Finkelstein DM; Donehower RC; Chang AY; Green M; Blum R; Hahn RG; Ruckdeschel JC
Med Pediatr Oncol; 1989; 17(3):197-201. PubMed ID: 2546026
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
Lad TE; Blough RR; Evrard M; Shevrin DP; Cobleigh MA; Johnson CM; Hange P
Invest New Drugs; 1989 Jul; 7(2-3):223-4. PubMed ID: 2551841
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of spirogermanium in patients with advanced colorectal carcinoma.
Ajani JA; Faintuch JS; McClure RK; Levin B; Boman BM; Krakoff IH
Invest New Drugs; 1986; 4(4):383-5. PubMed ID: 3583645
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study.
Pandya KJ; Kramar A; Asbury RF; Haller DG
Am J Clin Oncol; 1988 Aug; 11(4):496-8. PubMed ID: 3407630
[TBL] [Abstract][Full Text] [Related]
6. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Bui NB; Chauvergne J; Brunet R; Richaud P; Hoerni B; Lagarde C; Le Guillou M
Bull Cancer; 1986; 73(1):65-7. PubMed ID: 3779124
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and response criteria of the Eastern Cooperative Oncology Group.
Oken MM; Creech RH; Tormey DC; Horton J; Davis TE; McFadden ET; Carbone PP
Am J Clin Oncol; 1982 Dec; 5(6):649-55. PubMed ID: 7165009
[No Abstract] [Full Text] [Related]
8. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
Collins SJ; Ruscetti FW; Gallagher RE; Gallo RC
Proc Natl Acad Sci U S A; 1978 May; 75(5):2458-62. PubMed ID: 276884
[TBL] [Abstract][Full Text] [Related]
9. Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds.
Tanaka M; Levy J; Terada M; Breslow R; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1003-6. PubMed ID: 165480
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.
Ettinger DS; Finkelstein DM; Abeloff MD; Chang YC; Smith TJ; Oken MM; Ruckdeschel JC
Invest New Drugs; 1990 May; 8(2):183-5. PubMed ID: 2166720
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study.
Graziano SL; Lee K; Propert KJ; Tinsley R; Hayes DM; Green M; Comis RL
Med Pediatr Oncol; 1990; 18(1):22-6. PubMed ID: 2152956
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical trial of didemnin B in previously treated small cell lung cancer.
Shin DM; Holoye PY; Forman A; Winn R; Perez-Soler R; Dakhil S; Rosenthal J; Raber MN; Hong WK
Invest New Drugs; 1994; 12(3):243-9. PubMed ID: 7896544
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
